Opendata, web and dolomites

StableVax

Commercialisation of a world changing invention for the stabilisation and delivery of vaccines

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 StableVax project word cloud

Explore the words cloud of the StableVax project. It provides you a very rough idea of what is the project "StableVax" about.

invitation    optimum    auto    world    assist    saved    officer    invention    50    series    biological    saving    revolutionary    sensitive    inserted    vaccines    factory    transported    chief    distinguished    fails    tool    100    customer    temperatures    indispensable    containing    closely    chairman    company    cso    scientist    effectiveness    introducing    porous    organisation    special    incorporated    syringe    stablepharma    failings    keep    stabilise    standard    january    variety    scientific    guidance    removal    annually    accreditation    stored    eliminate    stabilisation    vaccination    2012    globe    dry    ltd    buffer    geneva    chain    constant    vaccine    frequently    storage    turn    millions    fighting    refrigerated    commercialise    pioneer    simply    wastage    vision    human    bruce    roser    stable    innovative    lives    relies    divided    useless    health    disable    material    tens    absorbed    cold    exposed    sub    disease    dissolved    left    dr    liquid    lose    global    rendered    designed    completely    error    compressible    monitored    finely    patented    temperature    units    unnecessary   

Project "StableVax" data sheet

The following table provides information about the project.

Coordinator
STABLEPHARMA LIMITED 

Organization address
address: 1 QUEEN SQUARE
city: BATH
postcode: BA1 2HA
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://stablepharma.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-09-01   to  2015-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    STABLEPHARMA LIMITED UK (BATH) coordinator 50˙000.00

Map

 Project objective

Vaccination is an indispensable tool in fighting disease, annually saving up tens of millions of lives saved across the globe. Vaccines are biological products that are sensitive to temperature change and can lose their effectiveness if exposed to sub optimum temperatures. The delivery of vaccines from the factory to the customer currently relies on a closely monitored cold chain process containing a series of refrigerated storage units, designed to keep the vaccine at a constant temperature. The system frequently fails for a variety of reasons, some technical and some simply due to human error. Currently 50% of the world’s vaccines are rendered useless due to the failings of the present refrigerated ‘cold chain’ delivery systems Stablepharma has a vision to eliminate the global cold chain and unnecessary vaccine wastage by introducing an innovative method to stabilise vaccines allowing them to be transported and stored at a wide-range of temperatures. Our technology involves the ~100% removal of liquid from vaccine dissolved in a special buffer, so that it is left in a completely stable and finely divided dry state absorbed into a, compressible, porous material that is in turn inserted into a standard auto-disable syringe. The process and invention was introduced to the WHO (World Health Organisation, Geneva) by invitation in 2012 and they have been able to assist the company with guidance in the development and accreditation process. Stablepharma Ltd was incorporated in January 2012 to commercialise a revolutionary vaccine stabilisation invention and process developed and patented by our Chief Scientific Officer (CSO) and Chairman, Dr Bruce Roser, a pioneer and distinguished scientist in this field.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "STABLEVAX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "STABLEVAX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

PREFERABLE (2019)

Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life

Read More  

AutoCRAT (2020)

Automated Cellular Robot-Assisted Technologies for translation of discovery-led research in Osteoarthritis

Read More  

SBR (2020)

SMART BONE REGENERATION

Read More